Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.

ABSTRACT:

Importance

Understanding Black vs White differences in pharmacotherapy efficacy and the underlying reasons is critically important to reducing tobacco-related health disparities.

Objective

To compare pharmacotherapy efficacy and examine variables to explain Black vs White differences in smoking abstinence.

Design, setting, and participants

This study is a secondary analysis of the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) double-blind, placebo-controlled, randomized clinical trial, which took place at clinical trial centers, academic centers, and outpatient clinics in 29 states in the US. US Black and White smokers who smoked 10 or more cigarettes per day with and without psychiatric comorbidity were enrolled between November 2011 and Janu

SUBMITTER: Nollen NL 

PROVIDER: S-EPMC7816102 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature